Anzeige
Mehr »
Login
Montag, 27.01.2025 Börsentäglich über 12.000 News von 683 internationalen Medien
US-Präsident setzt auf die Solana Blockchain! Diese Krypto-Perle profitiert enorm!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire (Europe)
1.726 Leser
Artikel bewerten:
(2)

Delisting of Securities of SmileDirectClub, Inc.; Bellerophon Therapeutics, Inc.; Elys Game Technology; Athersys, Inc.; Borqs Technologies; ContraFect Corporation; CohBar, Inc.; AgileThought, Inc.; Fat Projects Acquisition; Evelo Biosciences ...

Finanznachrichten News

NEW YORK, Dec. 26, 2023 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock of SmileDirectClub, Inc. SmileDirectClub, Inc.'s securities were suspended on October 4, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Bellerophon Therapeutics, Inc. Bellerophon Therapeutics, Inc.'s securities were suspended on October 16, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Elys Game Technology, Corp. Elys Game Technology, Corp.'s securities were suspended on October 17, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Athersys, Inc. Athersys, Inc.'s securities were suspended on October 18, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the ordinary shares of Borqs Technologies, Inc. Borqs Technologies, Inc.'s securities were suspended on October 27, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of ContraFect Corporation. ContraFect Corporation's securities were suspended on November 9, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of CohBar, Inc. CohBar, Inc.'s securities were suspended on November 19, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the Class A common stock and warrants of AgileThought, Inc. AgileThought, Inc.'s securities were suspended on November 24, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the Class A ordinary shares, warrants, and unit of Fat Projects Acquisition Corp. Fat Projects Acquisition Corp.'s securities were suspended on December 1, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Evelo Biosciences, Inc. Evelo Biosciences, Inc.'s securities were suspended on December 12, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock and warrants of Troika Media Group, Inc. Troika Media Group, Inc.'s securities were suspended on December 18, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Impel Pharmaceuticals Inc. Impel Pharmaceuticals Inc.'s securities were suspended on December 18, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Fresh Tracks Therapeutics, Inc. Fresh Tracks Therapeutics, Inc.'s securities were suspended on December 19, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock and warrants of Near Intelligence, Inc. Near Intelligence, Inc.'s securities were suspended on December 19, 2023, and have not traded on Nasdaq since that time.

For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at http://www.nasdaq.com. Nasdaq's rules governing the delisting of securities can be found in the Nasdaq Rule 5800 Series, available on the Nasdaq Web site: https://listingcenter.nasdaq.com/rulebook/nasdaq/rules/nasdaq-5800-series.


© 2023 GlobeNewswire (Europe)
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.